David R. Bauer
Lawyers
Filters
Revolution Medicines $1 billion at-the-market offering
We advised the sales agent on the offering
Amgen $4 billion notes offering
We advised the bookrunners on the offering
Coloplast acquisition of Uromedica
We are advising Coloplast on the transaction
BioMarin Pharmaceutical $850 million debut senior notes offering
We advised the representative of the initial purchasers
Coherus Oncology $50 million follow-on offering
We advised the joint book-running managers and representatives of the underwriters on the offering
AgomAb Therapeutics $200 million IPO
We advised the representatives of the several underwriters on the IPO
Eikon Therapeutics $381 million IPO
We advised the representatives of the several underwriters on the IPO
GE Vernova $2.6 billion debut senior notes offering
We advised the representatives of the underwriters on the offering
Maze Therapeutics $200 million at-the-market offering
We advised the sales agent on the offering
Perspective Therapeutics $175 million equity offering
We advised the representatives of the underwriters on the transaction